NDRAW - (ENDRA Life Sciences Inc.)

 NDRAWのチャート


 NDRAWの企業情報

symbol NDRAW
会社名
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種   
概要 事業概要 --     
本社所在地 --
代表者氏名
代表者役職名
電話番号
設立年月日 --
市場名 --
ipoyear 2017年
従業員数 -
url
nasdaq_url https://www.nasdaq.com/symbol/ndraw
adr_tso
EBITDA EBITDA ー
終値(lastsale) 0.5
時価総額(marketcap) 0
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 NDRAWのテクニカル分析


 NDRAWのニュース

   ENDRA Life Sciences to Report First Quarter 2022 Financial Results on May 12, 2022  2022/05/02 12:00:00 Business Wire
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NAFLD--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the first quarter of 2022 on Thursday, May 12, 2022 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate developments and answer questions. Partici
   ENDRA Life Sciences Inc. (NASDAQ: NDRA) Stock Seems Like A Good Option  2022/04/22 12:00:00 Stocks Register
ENDRA Life Sciences Inc. (NASDAQ:NDRA) shares, rose in value on Thursday, April 21, with the stock price up by 1.59% to the previous day’s close as strong demand from buyers drove the stock to $0.27. Actively observing the price movement in the last trading, the stock closed the session at $0.26, falling within a range … ENDRA Life Sciences Inc. (NASDAQ: NDRA) Stock Seems Like A Good Option Read More »
   Endra Life Sciences raises $8.7M YTD from common stock sale through ATM equity facility  2022/04/21 13:08:17 Seeking Alpha
Endra Life Sciences raised $8.7M year-to-date from the sale of common stock through its at the market, or ATM, equity facility.
   Thinking about buying stock in ENDRA Life Sciences, SeaChange, Protalix Biotherapeutics, Dingdong, or BigBear.ai?  2022/04/08 13:31:00 Benzinga
NEW YORK , April 8, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NDRA, SEAC, PLX, DDL, and BBAI. … Full story available on Benzinga.com
   16 Stocks Moving in Friday''s Pre-Market Session  2022/04/08 11:11:38 Benzinga
Gainers Biofrontera Inc. (NASDAQ: BFRI ) rose 34.5% to $5.44 in pre-market trading. ENDRA Life Sciences Inc. (NASDAQ: NDRA ) rose 31.9% to $0.5891 in pre-market trading after gaining over 10% on Thursday. HC Wainwright & Co. maintained ENDRA Life Sciences with a Buy and lowered the price target from $6 to $5. MedAvail Holdings, Inc. (NASDAQ: MDVL ) rose 29.1% to $1.82 in pre-market trading. MedAvail shares jumped 64% on Thursday after Ally Bridge Group reported in a Form4 filing a purchase of roughly 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share. Sunshine Biopharma, Inc. (NASDAQ: SBFM ) shares rose 20.7% to $11.65 in pre-market trading after surging 53% on Thursday. Aterian, Inc. (NASDAQ: … Full story available on Benzinga.com
   ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Portfolio with Issuance of 6th and 7th European Patents  2022/02/11 13:00:00 Business Wire
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NAFLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the European Patent Office (EPO) has issued two new patents to ENDRA, European Patent No. 3668382 (the ‘382 patent) titled “Method and System for Estimating Fractional Fat Content of an Object” and European Patent No. 3661416 (the ‘416 patent) titled “Method for Estimating Fractional Fat Content of an Object.” The ‘382 patent protects ENDRA''s meth
   ENDRA Life Voluntarily Withdraws 510(k) Application For Liver Fat Measuring System  2022/02/10 12:10:09 Benzinga
ENDRA Life Sciences Inc (NASDAQ: NDRA ) plans to voluntarily withdraw its 510(k) application , currently under FDA review for its TAEUS System. Instead, the Company will subsequently submit a De Novo application. TAEUS is initially focused on measuring fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Full story available on Benzinga.com
   Traders should follow this: ENDRA Life Sciences Inc. (NASDAQ:NDRA), Tanzanian Gold Corporation (AMEX:TRX)  2021/12/24 04:46:20 Stock Equity
ENDRA Life Sciences Inc. (NASDAQ:NDRA) with the stream of 6.79% also noticed, India Tanzanian Gold Corporation (AMEX:TRX) encountered a rapid change of -4.18% in the last hour of Thursdays trading The post Traders should follow this: ENDRA Life Sciences Inc. (NASDAQ:NDRA), Tanzanian Gold Corporation (AMEX:TRX) appeared first on Stocks Equity .
   ENDRA Life Sciences (NASDAQ:NDRA) Lowered to Hold at Zacks Investment Research  2021/12/15 06:06:42 Dakota Financial News
Zacks Investment Research lowered shares of ENDRA Life Sciences (NASDAQ:NDRA) from a buy rating to a hold rating in a research note issued to investors on Saturday morning, Zacks.com reports. According to Zacks, ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. []
   Goldman Sachs Group Inc. Makes New $104,000 Investment in ENDRA Life Sciences Inc. (NASDAQ:NDRA)  2021/12/13 09:12:41 Transcript Daily
Goldman Sachs Group Inc. acquired a new position in ENDRA Life Sciences Inc. (NASDAQ:NDRA) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 47,709 shares of the companys stock, valued at approximately $104,000. Goldman Sachs Group Inc. owned 0.11% of ENDRA Life Sciences at []
   ENDRA Life Sciences gets new US patent related to co''s TAEUS system  2021/10/13 12:11:26 Seeking Alpha
   ENDRA Life Sciences Inc.: ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences  2021/09/07 12:08:00 FinanzNachrichten
ANN ARBOR, MI / ACCESSWIRE / September 7, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in two
   ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences  2021/09/07 12:00:00 Wallstreet:Online
ANN ARBOR, MI / ACCESSWIRE / September 7, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in two upcoming virtual investment conferences.H.C.
   Endra Life Sciences EPS misses by $0.01  2021/08/12 20:36:24 Seeking Alpha
   ENDRA Life Sciences Inc.: ENDRA Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update  2021/08/12 20:08:00 FinanzNachrichten
Conference call begins at 4:30 p.m. Eastern time todayANN ARBOR, MI / ACCESSWIRE / August 12, 2021 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSou

 関連キーワード  (― 米国株 NDRAW ENDRA Life Sciences Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)